1.Significance of enriching the teaching materials in the eight-year program of clinical medicine of obstetrics and gynecology
Chinese Journal of Medical Education Research 2013;(10):1003-1004
The teaching goal of the eight-year program of clinical medicine emphasizes on high standard,starting point and requirement. In order to improve the teaching quality of obstetrics and gynecology,the teaching faculties constantly introduced the most updated concepts from overseas into their teaching experience ,including the concepts of practical translational medicine ,using of English multimedia teaching materials, real case study and the communication skills between doctors and patients. It showed that efforts put in the reformation of teaching material improved the learning interests of students and the professional skills of teachers.
2.Expression of C-X-C chemokine receptor type 7 in otorhinolaryngologic neoplasms.
Tian TANG ; Qing Jie XIA ; Xiaoming QIAO ; Mingrong XI
Singapore medical journal 2016;57(3):157-160
INTRODUCTIONC-X-C chemokine receptor type 7 (CXCR7) has recently been characterised as a novel receptor for the C-X-C motif chemokine 12 (CXCL12)/stromal cell-derived factor 1-alpha. CXCR7 has been thought to play an important role in the pathogenesis of chronic rhinosinusitis, angiogenesis and tumour metastasis. The present study aimed to examine the expression of CXCR7 in tissue samples of laryngeal cancer and maxillary sinus carcinoma to determine its role in the development of otorhinolaryngologic neoplasms.
METHODSSamples of otorhinolaryngologic neoplasms were obtained from 17 patients with either nasal polyps (n = 7), laryngeal cancer (n = 5) or maxillary sinus carcinoma (n = 5), and who underwent surgical resection at West China Hospital of Sichuan University. Total RNA was isolated and CXCR7 mRNA expression was examined and quantified by relative real-time reverse transcription polymerase chain reaction. A one-way analysis of variance was performed using SPSS Statistics version 11.0 (SPSS Inc, Chicago, IL, USA) to compare the CXCR7 mRNA levels among the three groups of patients.
RESULTSAll samples tested positive for CXCR7 mRNA. The quantitative results showed that the CXCR7 mRNA levels were highest in laryngeal cancer and lowest in maxillary sinus carcinoma neoplasms, although there was no significant difference among the three samples.
CONCLUSIONCXCL12 and its receptor CXCR7 may contribute to eosinophilic inflammation in patients with chronic sinusitis and nasal polyps. Our results also suggest that CXCR7 may play a role in the progression, metastasis and angiogenesis of otorhinolaryngologic tumours.
Aged ; Biomarkers, Tumor ; biosynthesis ; genetics ; Carcinoma, Squamous Cell ; genetics ; metabolism ; pathology ; Disease Progression ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Middle Aged ; Otorhinolaryngologic Neoplasms ; genetics ; metabolism ; pathology ; RNA, Neoplasm ; genetics ; Real-Time Polymerase Chain Reaction ; Receptors, CXCR ; biosynthesis ; genetics
3.Dihydroartemisinin and its anticancer activity against endometrial carcinoma and cervical cancer: involvement of apoptosis, autophagy and transferrin receptor.
Tian TANG ; Qingjie XIA ; Mingrong XI
Singapore medical journal 2021;62(2):96-103
INTRODUCTION:
Dihydroartemisinin (DHA) is a first-line antimalarial drug with relatively low toxicity. DHA has been speculated to possess a broad-spectrum antitumour effect. However, the potential value of DHA for the treatment of endometrial carcinoma or cervical cancer is unclear.
METHODS:
We used human endometrial cancer cells and cervical cancer cells to assess whether DHA alone or when combined with cisplatin would induce cell death. We aimed to elucidate the role of autophagy in DHA-induced cytotoxicity in both endometrial and cervical cancer cells, and explore the impact of DHA treatment on cell proliferation, apoptosis and autophagy.
RESULTS:
DHA alone or in combination with cisplatin induced cell death in a dose- and time-dependent manner. Caspase-3 mRNA and cleaved caspase-3 protein levels were markedly elevated following DHA treatment either in the presence or absence of cisplatin, suggesting a role of apoptosis in DHA-induced cell death. DHA treatment activated the autophagic pathway, as evidenced by increased monodansylcadaverine-positive staining, elevated microtubule-associated protein 1 light chain 3 (LC3)-II/LC3-I ratio, and enhanced p62/sequestosome 1 degradation. Inhibition of autophagy by 3-methyladenine further enhanced the cytotoxicity of DHA towards tumour cells. mRNA levels of transferrin receptor (TfR) were suppressed upon DHA treatment and knockdown of TfR by RNA interference caused further DHA induction of cancer cell death.
CONCLUSION
Our results suggest a clinical value for DHA in the treatment of endometrial carcinoma and cervical cancer. Our data revealed possible anticancer mechanisms of DHA that involve regulating apoptosis, autophagy pathway and levels of TfR.
4.Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists
Yingmei WANG ; Shiqian ZHANG ; Lihui WEI ; Zhongqiu LIN ; Xinyu WANG ; Jianliu WANG ; Keqin HUA ; Manhua CUI ; Jiandong WANG ; Shixuan WANG ; Wen DI ; Yudong WANG ; Ruifang AN ; Mingrong XI ; Ruixia GUO ; Qi ZHOU ; Xing XIE ; Fengxia XUE
Journal of Gynecologic Oncology 2020;31(4):e68-
The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients.